PDT Partners’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-49,389
| Closed | -$288K | – | 873 |
|
|
2025
Q1 | $288K | Buy |
+49,389
| New | +$260K | 0.02% | 618 |
|
|
2024
Q4 | – | Sell |
-17,664
| Closed | -$98.7K | – | 864 |
|
|
2024
Q3 | $98.7K | Buy |
+17,664
| New | +$124K | 0.01% | 697 |
|
|
2024
Q2 | – | Sell |
-12,975
| Closed | -$187K | – | 767 |
|
|
2024
Q1 | $187K | Buy |
+12,975
| New | +$215K | 0.02% | 581 |
|
|
2023
Q3 | – | Sell |
-14,659
| Closed | -$373K | – | 695 |
|
|
2023
Q2 | $373K | Sell |
14,659
-3,331
| -19% | -$96.2K | 0.05% | 423 |
|
|
2023
Q1 | $650K | Sell |
17,990
-37,725
| -68% | -$1.32M | 0.09% | 345 |
|
|
2022
Q4 | $2.21M | Buy |
55,715
+22,728
| +69% | +$945K | 0.36% | 71 |
|
|
2022
Q3 | $1.54M | Sell |
32,987
-4,855
| -13% | -$225K | 0.23% | 107 |
|
|
2022
Q2 | $1.66M | Buy |
37,842
+34,251
| +954% | +$1.88M | 0.15% | 220 |
|
|
2022
Q1 | $260K | Buy |
+3,591
| New | +$259K | 0.02% | 758 |
|
|
2021
Q1 | – | Sell |
-6,375
| Closed | -$1.1M | – | 901 |
|
|
2020
Q4 | $1.1M | Buy |
+6,375
| New | +$1.03M | 0.07% | 309 |
|
|
2019
Q2 | – | Sell |
-60,729
| Closed | -$3.8M | – | 476 |
|
|
2019
Q1 | $3.8M | Sell |
60,729
-26,383
| -30% | -$1.24M | 0.21% | 136 |
|
|
2018
Q4 | $3.39M | Buy |
87,112
+37,710
| +76% | +$1.68M | 0.19% | 152 |
|
|
2018
Q3 | $2.82M | Sell |
49,402
-3,098
| -6% | -$194K | 0.12% | 201 |
|
|
2018
Q2 | $4.19M | Buy |
+52,500
| New | +$4.35M | 0.16% | 170 |
|
|
2015
Q3 | – | Sell |
-32,989
| Closed | -$1.77M | – | 1620 |
|
|
2015
Q2 | $1.77M | Buy |
32,989
+14,786
| +81% | +$753K | 0.05% | 471 |
|
|
2015
Q1 | $872K | Buy |
+18,203
| New | +$790K | 0.02% | 833 |
|
Other funds holding NVRO
PDT Partners's NVRO Position: Q2 2025 in Review
PDT Partners sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 49,389 shares — an estimated $288K sold.
PDT Partners first reported a position in NVRO in Q1 2015 and held it in 16 quarters. The position peaked at $4.19M in Q2 2018. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.
- PDT Partners reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
- PDT Partners sold 49,389 NEVRO CORP. shares in Q2 2025, an estimated $288K.
- PDT Partners first reported a position in NEVRO CORP. in Q1 2015 and held it in 16 quarters.
- PDT Partners's NEVRO CORP. position peaked at $4.19M in Q2 2018.
- 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.
Based on PDT Partners's 13F filing for Q2 2025, filed 14 Aug 2025.